loadpatents
Patent applications and USPTO patent grants for Subramanyam; Chakrapani.The latest application filed is for "bifunctional cytotoxic agents containing the cti pharmacophore".
Patent | Date |
---|---|
Bifunctional cytotoxic agents containing the CTI pharmacophore Grant 11,365,263 - Maderna , et al. June 21, 2 | 2022-06-21 |
Bifunctional Cytotoxic Agents Containing The Cti Pharmacophore App 20210061923 - MADERNA; Andreas ;   et al. | 2021-03-04 |
Bifunctional cytotoxic agents containing the CTI pharmacophore Grant 10,870,706 - Maderna , et al. December 22, 2 | 2020-12-22 |
Tubulysin analogs and methods for their preparation Grant 10,723,727 - Subramanyam , et al. | 2020-07-28 |
Calicheamicin Deratives And Antibody Drug Conjugates Thereof App 20190345186 - Ahmad; Omar Khaled ;   et al. | 2019-11-14 |
Anti-edb Antibodies And Antibody-drug Conjugates App 20190269791 - HOOPER; Andrea Therese ;   et al. | 2019-09-05 |
Bifunctional cytotoxic agents Grant 10,391,182 - Maderna , et al. A | 2019-08-27 |
Tubulysin Analogs And Methods For Their Preparation App 20180362519 - SUBRAMANYAM; Chakrapani ;   et al. | 2018-12-20 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180346477 - GRAY; DAVID LAWRENCE FIRMAN ;   et al. | 2018-12-06 |
Bifunctional Cytotoxic Agents App 20180339060 - MADERNA; Andreas ;   et al. | 2018-11-29 |
Bifunctional cytotoxic agents Grant 10,086,085 - Maderna , et al. October 2, 2 | 2018-10-02 |
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,077,272 - Gray , et al. September 18, 2 | 2018-09-18 |
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20180200253 - COE; JOTHAM WADSWORTH ;   et al. | 2018-07-19 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180072750 - GRAY; DAVID LAWRENCE FIRMAN ;   et al. | 2018-03-15 |
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,868,744 - Gray , et al. January 16, 2 | 2018-01-16 |
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,856,263 - Gray , et al. January 2, 2 | 2018-01-02 |
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,850,232 - Gray , et al. December 26, 2 | 2017-12-26 |
Spliceostatin analogs and methods for their preparation Grant 9,764,040 - Subramanyam , et al. September 19, 2 | 2017-09-19 |
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders Grant 9,751,877 - Pettersson , et al. September 5, 2 | 2017-09-05 |
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,688,698 - Gray , et al. June 27, 2 | 2017-06-27 |
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20170165270 - COE; JOTHAM WADSWORTH ;   et al. | 2017-06-15 |
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,617,275 - Coe , et al. April 11, 2 | 2017-04-11 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20170037053 - GRAY; DAVID LAWRENCE FIRMAN ;   et al. | 2017-02-09 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20170037049 - GRAY; DAVID LAWRENCE FIRMAN ;   et al. | 2017-02-09 |
Spliceostatin Analogs And Methos For Their Preparation App 20170014523 - SUBRAMANYAM; Chakrapani ;   et al. | 2017-01-19 |
Substituted 1,7-naphthyridines as dopamine D1 ligands Grant 9,540,352 - Gray , et al. January 10, 2 | 2017-01-10 |
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,527,843 - Davoren , et al. December 27, 2 | 2016-12-27 |
Spliceostatin analogs and methods for their preparation Grant 9,504,669 - Subramanyam , et al. November 29, 2 | 2016-11-29 |
Bifunctional Cytotoxic Agents Containing The Cti Pharmacophore App 20160271270 - MADERNA; Andreas ;   et al. | 2016-09-22 |
Novel Bicyclic Pyridinones As Gamma-secretase Modulators App 20160229847 - Pettersson; Martin Youngjin ;   et al. | 2016-08-11 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20160200711 - GRAY; DAVID LAWRENCE FIRMAN ;   et al. | 2016-07-14 |
Cytotoxic peptides and antibody drug conjugates thereof Grant 9,249,186 - Doroski , et al. February 2, 2 | 2016-02-02 |
Novel Pyrido[1,2-a]Pryazines And Their Use in the Treatment of Neurodegenerative and Neurological Disorders App 20160024088 - Pettersson; Martin Youngjin ;   et al. | 2016-01-28 |
Spliceostatin Analogs And Methods For Their Preparation App 20160022626 - SUBRAMANYAM; Chakrapani ;   et al. | 2016-01-28 |
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20150344490 - COE; JOTHAM WADSWORTH ;   et al. | 2015-12-03 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150344474 - DAVOREN; JENNIFER ELIZABETH ;   et al. | 2015-12-03 |
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders Grant 9,193,726 - Pettersson , et al. November 24, 2 | 2015-11-24 |
Cytotoxic Peptides And Antibody Drug Conjugates Thereof App 20150307551 - DOROSKI; Matthew David ;   et al. | 2015-10-29 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150307522 - GRAY; DAVID LAWRENCE FIRMAN ;   et al. | 2015-10-29 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150307494 - GRAY; DAVID LAWRENCE FIRMAN ;   et al. | 2015-10-29 |
Spliceostatin analogs and methods for their preparation Grant 9,169,264 - Subramanyam , et al. October 27, 2 | 2015-10-27 |
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20150291625 - COE; JOTHAM WADSWORTH ;   et al. | 2015-10-15 |
Cytotoxic peptides and antibody drug conjugates thereof Grant 9,138,486 - Doroski , et al. September 22, 2 | 2015-09-22 |
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,133,190 - Davoren , et al. September 15, 2 | 2015-09-15 |
Bifunctional Cytotoxic Agents App 20150209445 - MADERNA; Andreas ;   et al. | 2015-07-30 |
Bicyclic pyridinones Grant 9,067,934 - Pettersson , et al. June 30, 2 | 2015-06-30 |
Novel Pyrido[1,2-a]Pryazines And Their Use In The Treatment of Neurodegenerative and Neurological Disorders App 20150072990 - Pettersson; Martin Youngjin ;   et al. | 2015-03-12 |
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders Grant 8,916,564 - Pettersson , et al. December 23, 2 | 2014-12-23 |
Cytotoxic Peptides And Antibody Drug Conjugates Thereof App 20140363452 - DOROSKI; Matthew David ;   et al. | 2014-12-11 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20140336176 - DAVOREN; JENNIFER ELIZABETH ;   et al. | 2014-11-13 |
Cytotoxic peptides and antibody drug conjugates thereof Grant 8,828,401 - Doroski , et al. September 9, 2 | 2014-09-09 |
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 8,822,494 - Davoren , et al. September 2, 2 | 2014-09-02 |
Spliceostatin Analogs And Methods For Their Preparation App 20140134193 - SUBRAMANYAM; Chakrapani ;   et al. | 2014-05-15 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20140128374 - DAVOREN; JENNIFER ELIZABETH ;   et al. | 2014-05-08 |
Bicyclic pyridinones Grant 8,697,673 - Pettersson , et al. April 15, 2 | 2014-04-15 |
Novel Bicyclic Pyridinones App 20140088111 - Pettersson; Martin Youngjin ;   et al. | 2014-03-27 |
Novel Bicyclic Pyridinones App 20140045790 - Pettersson; Martin Youngjin ;   et al. | 2014-02-13 |
Fused pyridine compounds as casein kinase inhibitors Grant 8,536,164 - Butler , et al. September 17, 2 | 2013-09-17 |
Compounds as casein kinase inhibitors Grant 8,518,944 - Subramanyam , et al. August 27, 2 | 2013-08-27 |
Cytotoxic Peptides And Antibody Drug Conjugates Thereof App 20130129753 - DOROSKI; Matthew David ;   et al. | 2013-05-23 |
Novel Bicyclic Pyridinones App 20120252758 - Pettersson; Martin Youngjin ;   et al. | 2012-10-04 |
Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators App 20120202787 - am Ende; Christopher William ;   et al. | 2012-08-09 |
Novel Fused Pyridine Compounds As Casein Kinase Inhibitors App 20120157440 - BUTLER; TODD W. ;   et al. | 2012-06-21 |
Substituted Heterocyclic Derivatives And Their Pharmaceutical Use And Compositions App 20120065188 - Brickner; Steven Joseph ;   et al. | 2012-03-15 |
Novel Compounds As Casein Kinase Inhibitors App 20110098272 - Subramanyam; Chakrapani ;   et al. | 2011-04-28 |
Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and Compositions App 20110092480 - Brickner; Steven Joseph ;   et al. | 2011-04-21 |
Benzamide inhibitors of the P2X.sub.7 receptor Grant 7,553,972 - Dombrowski , et al. June 30, 2 | 2009-06-30 |
Substituted Heterocyclic Derivatives And Their Pharmaceutical Use And Compositions App 20080280879 - BRICKNER; Steven Jospeh ;   et al. | 2008-11-13 |
Benzamide, heteroarylamide and reverse amides Grant 7,235,549 - Duplantier , et al. June 26, 2 | 2007-06-26 |
Benzamide Inhibitors of the P2X7 Receptor App 20070142329 - Dombroski; Mark A. ;   et al. | 2007-06-21 |
Benzamide, heteroarylamide and reverse amides Grant 7,214,677 - Duplantier , et al. May 8, 2 | 2007-05-08 |
Benzamide inhibitors of the P2X.sub.7 receptor Grant 7,186,742 - Dombroski , et al. March 6, 2 | 2007-03-06 |
Benzamide inhibitors of the P2X7 receptor App 20060217430 - Dombroski; Mark A. ;   et al. | 2006-09-28 |
Benzamide inhibitors of the P2X.sub.7 receptor Grant 7,071,223 - Dombroski , et al. July 4, 2 | 2006-07-04 |
Benzamide, heteroarylamide and reverse amides App 20060058302 - Duplantier; Allen J. ;   et al. | 2006-03-16 |
Benzamide inhibitors of the P2X7 receptor App 20050009900 - Dombroski, Mark A. ;   et al. | 2005-01-13 |
Urea derivatives useful as anticancer agents App 20030191279 - Goldstein, Steven Wayne ;   et al. | 2003-10-09 |
Benzamide, heteroarylamide and reverse amides App 20030186981 - Duplantier, Allen J. ;   et al. | 2003-10-02 |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof Grant 5,874,432 - Dunlap , et al. February 23, 1 | 1999-02-23 |
2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof Grant 5,856,349 - Dunlap , et al. January 5, 1 | 1999-01-05 |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof Grant 5,650,422 - Dunlap , et al. July 22, 1 | 1997-07-22 |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof Grant 5,596,012 - Dunlap , et al. January 21, 1 | 1997-01-21 |
Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof Grant 5,569,655 - Dority, Jr. , et al. October 29, 1 | 1996-10-29 |
2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof Grant 5,488,062 - Dunlap , et al. January 30, 1 | 1996-01-30 |
2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors Grant 5,376,653 - Dunlap , et al. December 27, 1 | 1994-12-27 |
Use of saccharin derivatives as proteolytic enzyme inhibitors Grant 5,371,074 - Dunlap , et al. December 6, 1 | 1994-12-06 |
2-saccharinylmethyl aryl carboxylate Grant 5,250,696 - Dunlap , et al. October 5, 1 | 1993-10-05 |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof Grant 5,236,917 - Dunlap , et al. August 17, 1 | 1993-08-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.